Gavi, the Vaccine Alliance was founded to ensure a secure supply of vaccines at affordable prices to developing countries. Since its inception, private sector partnerships, through the mobilisation of resources or the leveraging of expertise and innovation, have been integral to Gavi's success.
Partnering with Gavi creates an opportunity for private sector partners to join a global alliance. Together, we can save lives, create sustainable socio-economic benefits and take a leading role in global development.
Gavi has already protected an entire generation of children and is now working to protect the next by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. With the support of it sprivate sector partners, through innovative financing and the latest technology – from drones to biometrics – it will continue to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency.
Supporting Gavi CORE immunisation programmes increases equitable and sustainable use of vaccines, transforming the lives of individuals, helping to boost the economies of lower-income countries and making the world safer for everyone. For more information on Gavi’s priorities see here.
By establishing strategic partnerships with leaders in business and industry, we are able to use the private sector's financial resources, operational expertise, thought-leadership and innovation to support our goals on vaccine coverage and equity.
We work with private sector partners to develop long-term relationships and create sustainable impact. Corporations can partner with Gavi by sharing industry expertise, technology, and know how to overcome the stubborn bottlenecks that prevent vaccines being available for every child.
Increasing demand for new vaccines is placing ever greater pressure on immunisation delivery systems in developing countries. We are continuously looking to foster innovation, in close collaboration with private businesses and the technology industry, to address these issues.
Launched in 2011, the Matching Fund doubles multiplies private sector partners' impact by doubling their investment. By encouraging business to invest in immunisation, the Gavi Matching Fund has been a critical component in the expansion of our private sector engagement.
Using mobile technology to save lives in India
A campaign using mobile phone calls and voice-note storytelling boosted immunisation and handwashing demand and uptake in Uttar Pradesh, India.
The US$ 500 million challenge: Gavi launches INFUSE 2.0 to scale up innovations in immunisation
INFUSE is an innovation scaling hub that matches investors with innovators and entrepreneurs to help scale up new ways to improve vaccination coverage in lower-income countries
Gavi’s first multisectoral private sector partnership to include nutrition as part of holistic approach to disease prevention.
Redefining the role of fathers is helping to boost vaccination uptake in rural India
Involving fathers in their children’s health decisions improves immunisation rates and hygiene in India.
How story-telling is helping girls access the HPV vaccine in Ethiopia and Tanzania
Girls and women hold the key to improving access to healthcare for families across Ethiopia and Tanzania, starting with the HPV vaccine.
5 questions with Unilever’s Rebecca Marmot
Gavi has been working with Unilever since 2017 to raise awareness of both immunisation and handwashing across India. VaccinesWork spoke to Rebecca Marmot, Unilever’s Chief Sustainability Officer, about the Safal Shuruaat programme, why…
Combining health datasets is helping polio vaccination efforts in Pakistan
Pakistan is one of just two countries where the polio virus remains endemic. Challenges remain in identifying and vaccinating all children, but data management software is providing a way forward.
How digitisation is ensuring no child is left behind
A technology NGO is replacing paper vaccination records with simple, cost-effective technical solutions in the Gambia and Uganda.
5 questions with Parsyl’s Souleymane Sawadogo
Souleymane Sawadogo, Vice President of Global Health at Parsyl, tells us how innovation and data are revolutionising vaccine supply chains.
Better tracking is ensuring vaccines get where they’re needed in under-resourced regions
What does it take to get a vaccine made in India to a rural clinic in Malawi, or a diagnostic kit assembled in China to a town in Senegal? Miles of travel, hours of storage and lots of planning. But it’s an imperfect process, thanks to an absence…
How data can reduce waste and get vaccines where they need to be
Real-time temperature data across the vaccine cold chain can help identify problems or risks in the supply chain.
‘The biggest lesson we learned was to just ask’: 5 questions with the Aviation Coalition
Aviation links the world. The sector has been at the heart of the COVID pandemic, from adapting to travel restrictions to transporting vaccines and vital health equipment. Find out how a coalition of companies has been working together to support…
3 health lessons for business from the COVID-19 pandemic
The link between our physical and economic health was made painfully clear during the pandemic, but what lessons can businesses take forward from COVID-19?
How mobile money can transform access to healthcare
Mobile money can help the 1.7 billion people who lack a bank account to access financial services. And it could also have a powerful role to play in healthcare.
How new training approaches are transforming health workers’ ability to deliver vaccines
The pandemic made the challenge of training health workers in lower-income countries even harder. To counter the huge impact COVID-19 is having on health systems worldwide, a collaboration between Gavi and The Rockefeller Foundation is improving…
‘We can’t overstate the power of efficiency’: 5 questions with IFPW
Covering 70% of pharmaceutical goods moved around the world, IFPW is a global group of wholesalers and distributors. Find out how they have been working with Gavi to improve soft skills in the world’s immunization and pharmaceutical supply…
How the planes of the future will create a healthier planet
The effects of climate change may lead to future pandemics. As the aviation industry looks to the future, cleaner fuels and electric planes will be key to reducing aviation’s impact on the climate.
How a private-public partnership is training supply chain professionals in the global south
‘Soft skills’, from motivating a team to tapping into networks, provide the vital oil that keeps supply chains moving smoothly. A programme called STEP is bringing together businesses and the public sector to help healthcare managers in the…
Are chatbots better than humans at fighting vaccine hesitancy?
Could artificial intelligence succeed where people have failed in helping people overcome their fears about vaccines?
Why we support COVAX: Mastercard
Mastercard, a long-standing partner of Gavi, recently committed US$ 28 million to the Gavi COVAX AMC, to ensure vaccines are accessible to those that needed them the most, no matter where they live. Vaccines Work spoke to Michael Froman to learn…
COVAX vaccines take to the air by drone
Ghana is not only the first country to receive a shipment of COVAX vaccines, but it will be the first to broaden its reach by delivering them by drone. The new partnership with Zipline and UPS Foundation will see 2.5 million doses delivered this…
Q&A with Keller C. Rinaudo, CEO and Co-Founder of Zipline
Zipline is a California-based automated logistics company that uses autonomous drones to make on-demand, emergency deliveries of high priority products, including emergency and routine vaccines and other health products.